GlassScriptPhysician profile
Hugh Cahill
NPI 1982091666
$2,154.11
in general payments reported to CMS, 2019-2025
13 companies · $428 in 2025
The $428 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $188 · 2021: $128 · 2022: $300 · 2023: $585 · 2024: $526 · 2025: $428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,538.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,359.50 | 2021-2025 | Qulipta, Ubrelvy, Botox |
| Allergan, INC. | $187.79 | 2020 | |
| Ceribell, INC. | $160.53 | 2023 | Ceribell Rapid Response Eeg |
| Lilly USA, LLC | $67.96 | 2024-2025 | Kisunla, Amyvid |
| Averitas Pharma INC. | $64.24 | 2024-2025 | Qutenza |
| Tanabe Pharma America, INC. | $62.06 | 2022-2025 | Radicava |
| Eisai INC. | $60.27 | 2024-2025 | |
| Lundbeck LLC | $51.92 | 2025 | Rexulti, Vyepti |
| Biohaven Pharmaceutical Holding Company LTD. | $38.56 | 2022 | |
| Ge Healthcare | $38.29 | 2025 | |
| Impel Pharmaceuticals INC. | $24.91 | 2023 | Trudhesa |
| Axsome Therapeutics, INC. | $23.97 | 2025 | Symbravo |
| Teva Pharmaceuticals USA, INC. | $14.11 | 2023 | Ajovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hugh Cahill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.